MicroRNA Regulation of Airway Inflammation and Airway Smooth Muscle Function: Relevance to Asthma

Drug Development Research

Volumn 76, Issue 6, 2015, Pages 286-295

  Deshpande, D A ^a   Dileepan, M ^b   Walseth, T T ^c   Subramanian, S ^c   Kannan, M S ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

airway hyperresponsiveness; allergic airway disease; microRNA therapeutics; murine asthma models

Indexed keywords

BIOLOGICAL MARKER; CD38 ANTIGEN; MESSENGER RNA; MICRORNA; MICRORNA 10A; MICRORNA 126; MICRORNA 133A; MICRORNA 140 3P; MICRORNA 155; MICRORNA 21; MICRORNA 25; MICRORNA 708; UNCLASSIFIED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ASTHMA; BREATHING MUSCLE; CELL PROLIFERATION; DRUG TARGETING; HUMAN; NONHUMAN; REGULATORY MECHANISM; RESPIRATORY FUNCTION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; REVIEW; ANIMAL; GENETICS; INFLAMMATION; LUNG; METABOLISM; SMOOTH MUSCLE;

ANIMALS; ASTHMA; HUMANS; INFLAMMATION; LUNG; MICRORNAS; MUSCLE, SMOOTH;

EID: 84941258913     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.21267     Document Type: Review

References (79)

1. Aiken C., 1997. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J Virol 71: 5871-5877.
2. Alkhouri H, Cha V, Tong K, Moir LM, Armour CL, Hughes JM., 2014. Human lung mast cell products regulate airway smooth muscle CXCL10 levels. J Allergy (Cairo) 2014: 875105.
3. Alrashdan YA, Alkhouri H, Chen E, Lalor DJ, Poniris M, Henness S, Brightling CE, Burgess JK, Armour CL, Ammit AJ, et al., 2012. Asthmatic airway smooth muscle CXCL10 production: mitogen-activated protein kinase JNK involvement. Am J Physiol Lung Cell Mol Physiol 302: L1118-L1127.
4. Ammit AJ, Hoffman RK, Amrani Y, Lazaar AL, Hay DW, Torphy TJ, Penn RB, Panettieri RA Jr., 2000. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate. Am J Respir Cell Mol Biol 23: 794-802.
5. Ammit AJ, Lazaar AL, Irani C, O'Neill GM, Gordon ND, Amrani Y, Penn RB, Panettieri RA Jr., 2002. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am J Respir Cell Mol Biol 26: 465-474.
6. Asai T, Oku N., 2014. Systemic delivery of small RNA using lipid nanoparticles. Biol Pharm Bull 37: 201-205.
7. Bader AG, Brown D, Winkler M., 2010. The promise of microRNA replacement therapy. Cancer Res 70: 7027-7030.
8. Boden D, Pusch O, Lee F, Tucker L, Shank PR, Ramratnam B., 2003. Promoter choice affects the potency of HIV-1 specific RNA interference. Nucleic Acids Res 31: 5033-5038.
9. Brightling CE, Ammit AJ, Kaur D, Black JL, Wardlaw AJ, Hughes JM, Bradding P., 2005. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 171: 1103-1108.
10. Campbell K, Booth SA., 2015. MicroRNA in neurodegenerative drug discovery: the way forward? Expert Opin Drug Discov 10: 9-16.
11. Chiba Y, Takada Y, Miyamoto S, MitsuiSaito M, Karaki H, Misawa M., 1999. Augmented acetylcholine-induced, Rho-mediated Ca2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats. Br J Pharmacol 127: 597-600.
12. Chiba Y, Tanabe M, Goto K, Sakai H, Misawa M., 2009. Down-regulation of miR-133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells. Am J Respir Crit Care Med 180: 713-719.
13. Chiba Y, Ueno A, Shinozaki K, Takeyama H, Nakazawa S, Sakai H, Misawa M., 2005. Involvement of RhoA-mediated Ca2+ sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice. Respir Res 6: 4.
14. Collison A, Herbert C, Siegle JS, Mattes J, Foster PS, Kumar RK., 2011. Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target. BMC Pulm Med 11: 29.
15. Comer BS, Camoretti-Mercado B, Kogut PC, Halayko AJ, Solway J, Gerthoffer WT., 2015. Cyclooxygenase-2 and microRNA-155 expression are elevated in asthmatic airway smooth muscle cells. Am J Respir Cell Mol Biol 52: 438-447.
16. Davis S, Lollo B, Freier S, Esau C., 2006. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res 34: 2294-2304.
17. Deshpande DA, Dogan S, Walseth TF, Miller SM, Amrani Y, Panettieri RA, Kannan MS., 2004. Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. Am J Respir Cell Mol Biol 31: 36-42.
18. Deshpande DA, White TA, Dogan S, Walseth TF, Panettieri RA, Kannan MS., 2005a. CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 288: L773-L788.
19. Deshpande DA, White TA, Guedes AG, Milla C, Walseth TF, Lund FE, Kannan MS., 2005b. Altered airway responsiveness in CD38-deficient mice. Am J Respir Cell Mol Biol 32: 149-156.
20. Dileepan M, Jude JA, Rao SP, Walseth TF, Panettieri RA, Subramanian S, Kannan MS., 2014. MicroRNA-708 regulates CD38 expression through signaling pathways JNK MAP kinase and PTEN/AKT in human airway smooth muscle cells. Respir Res 15: 107.
21. Dowell ML, Lavoie TL, Solway J, Krishnan R., 2014. Airway smooth muscle: a potential target for asthma therapy. Curr Opin Pulm Med 20: 66-72.
22. Ebert MS, Neilson JR, Sharp PA., 2007. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4: 721-726.
23. Ebert MS, Sharp PA., 2010. Emerging roles for natural microRNA sponges. Curr Biol 20: R858-R861.
24. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, et al., 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98.
25. Fabbri E, Brognara E, Borgatti M, Lampronti I, Finotti A, Bianchi N, Sforza S, Tedeschi T, Manicardi A, Marchelli R, et al., 2011. miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs. Epigenomics 3: 733-745.
26. Gao YD, Cao J, Li P, Huang G, Yang J., 2014. Th2 cytokine-primed airway smooth muscle cells induce mast cell chemotaxis via secretion of ATP. J Asthma 51: 997-1003.
27. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, Presky DH., 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 16: 495-521.
28. Ghaffar O, Hamid Q, Renzi PM, Allakhverdi Z, Molet S, Hogg JC, Shore SA, Luster AD, Lamkhioued B., 1999. Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. Am J Respir Crit Care Med 159: 1933-1942.
29. Gruh I, Wunderlich S, Winkler M, Schwanke K, Heinke J, Blomer U, Ruhparwar A, Rohde B, Li RK, Haverich A, et al., 2008. Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors. J Gene Med 10: 21-32.
30. Guedes AG, Deshpande DA, Dileepan M, Walseth TF, Panettieri RA Jr, Subramanian S, Kannan MS., 2015a. CD38 and airway hyper-responsiveness: studies on human airway smooth muscle cells and mouse models. Can J Physiol Pharmacol 93: 145-153.
31. Guedes AG, Jude JA, Paulin J, Kita H, Lund FE, Kannan MS., 2008. Role of CD38 in TNF-alpha-induced airway hyperresponsiveness. Am J Physiol Lung Cell Mol Physiol 294: L290-L299.
32. Guedes AG, Jude JA, Paulin J, Rivero-Nava L, Kita H, Lund FE, Kannan MS., 2015b. Airway responsiveness in CD38-deficient mice in allergic airway disease: studies with bone marrow chimeras. Am J Physiol Lung Cell Mol Physiol 308: L485-L493.
33. Guedes AG, Paulin J, Rivero-Nava L, Kita H, Lund FE, Kannan MS., 2006. CD38-deficient mice have reduced airway hyperresponsiveness following IL-13 challenge. Am J Physiol Lung Cell Mol Physiol 291: L1286-L1293.
34. Halwani R, Al-Abri J, Beland M, Al-Jahdali H, Halayko AJ, Lee TH, Al-Muhsen S, Hamid Q., 2011. CC and CXC chemokines induce airway smooth muscle proliferation and survival. J Immunol 186: 4156-4163.
35. Hammond SM., 2015. An overview of microRNAs. Adv Drug Deliv Rev 87: 3-14.
36. Hata A, Lieberman J., 2015. Dysregulation of microRNA biogenesis and gene silencing in cancer. Sci Signal 8: 1-11.
37. Hinkel R, Ng JK, Kupatt C., 2014. Targeting microRNAs for cardiovascular therapeutics in coronary artery disease. Current Opin Cardiol 29: 586-594.
38. Holgate ST., 2008. Pathogenesis of asthma. Clin Exp Allergy. 38: 872-897.
39. Hu R, Pan W, Fedulov AV, Jester W, Jones MR, Weiss ST, Panettieri RA Jr, Tantisira K, Lu Q., 2014. MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway. FASEB J 28: 2347-2357.
40. John AE, Zhu YM, Brightling CE, Pang L, Knox AJ., 2009. Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-kappa B p65, C/EBP beta, and RNA polymerase II binding to the CXCL8 promoter. J Immunol 183: 4682-4692.
41. John M, Hirst SJ, Jose PJ, Robichaud A, Berkman N, Witt C, Twort CH, Barnes PJ, Chung KF., 1997. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J Immunol 158: 1841-1847.
42. Jude JA, Dileepan M, Subramanian S, Solway J, Panettieri RA Jr, Walseth TF, Kannan MS., 2012. miR-140-3p regulation of TNF-alpha-induced CD38 expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 303: L460-L468.
43. Khan MA., 2013. Inflammation signals airway smooth muscle cell proliferation in asthma pathogenesis. Multidiscip Respir Med 8: 11.
44. Knox AJ, Corbett L, Stocks J, Holland E, Zhu YM, Pang L., 2001. Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB Journal 15: 2480-2488.
45. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, et al., 2009. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137: 1005-1017.
46. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M., 2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
47. Kuhn AR, Schlauch K, Lao R, Halayko AJ, Gerthoffer WT, Singer CA., 2010. MicroRNA expression in human airway smooth muscle cells: role of miR-25 in regulation of airway smooth muscle phenotype. Am J Respir Cell Mol Biol 42: 506-513.
48. Lambrecht BN, Hammad H., 2015. The immunology of asthma. Nat Immunol 16: 45-56.
49. Lan H, Zhong H, Gao Y, Ren D, Chen L, Zhang D, Lai W, Xu J, Luo Y., 2010. The PTEN tumor suppressor inhibits human airway smooth muscle cell migration. Int J Mol Med 26: 893-899.
50. Lazzeri N, Belvisi MG, Patel HJ, Chung KF, Yacoub MH, Mitchell JA., 2001. RANTES release by human airway smooth muscle: effects of prostaglandin E(2) and fenoterol. Eur J Pharmacol 433: 231-235.
51. Li Z, Rana TM., 2014. Therapeutic targeting of microRNAs: current status and future challenges. Nature Rev Drug Discov 13: 622-638.
52. Love TM, Moffett HF, Novina CD., 2008. Not miR-ly small RNAs: big potential for microRNAs in therapy. J Allergy Clin Immunol 121: 309-319.
53. Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta N, Steer BM, Ingram AJ, Gupta M, Al-Omran M, et al., 2012. MicroRNA-145 targeted therapy reduces atherosclerosis. Circulation 126 (11 Suppl 1): S81-S90.
54. Loya CM, Lu CS, Van Vactor D, Fulga TA., 2009. Transgenic microRNA inhibition with spatiotemporal specificity in intact organisms. Nat Methods 6: 897-903.
55. Lu TX, Munitz A, Rothenberg ME., 2009. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 182: 4994-5002.
56. Lund FE., 2006. Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity. Mol Med 12: 328-333.
57. Malavasi F, Deaglio S, Damle R, Cutrona G, Ferrarini M, Chiorazzi N., 2011. CD38 and chronic lymphocytic leukemia: a decade later. Blood 118: 3470-3478.
58. Malmhall C, Alawieh S, Lu Y, Sjostrand M, Bossios A, Eldh M, Radinger M., 2014. MicroRNA-155 is essential for T(H)2-mediated allergen-induced eosinophilic inflammation in the lung. J Allergy Clin Immunol 133: 1429-1438, 1438 e1-e7.
59. Mattes J, Collison A, Plank M, Phipps S, Foster PS., 2009. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci USA 106: 18704-18709.
60. Okamoto H, Takasawa S, Nata K., 1997. The CD38-cyclic ADP-ribose signalling system in insulin secretion: molecular basis and clinical implications. Diabetologia 40: 1485-1491.
61. Ortega VE, Meyers DA, Bleecker ER., 2015. Asthma pharmacogenetics and the development of genetic profiles for personalized medicine. Pharmacogenomics Pers Med 8: 9-22.
62. Papaioannou AI, Kostikas K, Zervas E, Kolilekas L, Papiris S, Gaga M., Control of asthma in real life: still a valuable goal? 2015. Eur Respir Rev 2015 24: 361-369
63. Perry MM, Baker JE, Gibeon DS, Adcock IM, Chung KF., 2014. Airway smooth muscle hyperproliferation is regulated by microRNA-221 in severe asthma. Am J Respir Cell Mol Biol 50: 7-17.
64. Prakash YS., 2013. Airway smooth muscle in airway reactivity and remodeling: what have we learned? Am J Physiol Lung Cell Mol Physiol 305: L912-L933.
65. Prefontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, Lemiere C, Martin JG, Hamid Q., 2009. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 183: 5094-5103.
66. Ray A, Oriss TB, Wenzel SE., 2015. Emerging molecular phenotypes of asthma. Am J Physiol Lung Cell Mol Physiol 308: L130-L140.
67. Roff AN, Craig TJ, August A, Stellato C, Ishmael FT., 2014. MicroRNA-570-3p regulates HuR and cytokine expression in airway epithelial cells. Am J Clin Exp Immunol 3: 68-83.
68. Shen J, Hung MC., 2015. Signaling-mediated regulation of MicroRNA processing. Cancer Res 75: 783-791.
69. Shi B, Keough E, Matter A, Leander K, Young S, Carlini E, Sachs AB, Tao W, Abrams M, Howell B, et al., 2011. Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery. J Histochem Cytochem 59: 727-740.
70. Singh SR, Sutcliffe A, Kaur D, Gupta S, Desai D, Saunders R, Brightling CE., 2014. CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration. Allergy 69: 1189-1197.
71. Steer CJ, Subramanian S., 2012. Circulating microRNAs as biomarkers: a new frontier in diagnostics. Liver Transpl 18: 265-269.
72. Todesco M, Rubio-Somoza I, Paz-Ares J, Weigel D., 2010. A collection of target mimics for comprehensive analysis of microRNA function in Arabidopsis thaliana. PLoS Genet 6: e1001031.
73. Trang P, Wiggins JF, Daige CL, Cho C, Omotola M, Brown D, Weidhaas JB, Bader AG, Slack FJ., 2011. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther 19: 1116-1122.
74. Trinchieri G., 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146.
75. van der Velden JL, Hoffman SM, Alcorn JF, Tully JE, Chapman DG, Lahue KG, Guala AS, Lundblad LK, Aliyeva M, Daphtary N, et al., 2014. Absence of c-Jun NH2-terminal kinase 1 protects against house dust mite-induced pulmonary remodeling but not airway hyperresponsiveness and inflammation. Am J Physiol Lung Cell Mol Physiol 306: L866-L875.
76. Wang WC, Juan AH, Panebra A, Liggett SB., 2011. MicroRNA let-7 establishes expression of beta2-adrenergic receptors and dynamically down-regulates agonist-promoted down-regulation. Proc Natl Acad Sci USA 108: 6246-6251.
77. Williams AE, Larner-Svensson H, Perry MM, Campbell GA, Herrick SE, Adcock IM, Erjefalt JS, Chung KF, Lindsay MA., 2009. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PloS One 4: e5889.
78. Wu XB, Wang MY, Zhu HY, Tang SQ, You YD, Xie YQ., 2014. Overexpression of microRNA-21 and microRNA-126 in the patients of bronchial asthma. Int J Clin Exp Med 7: 1307-1312.
79. Zheng G, Ambros V, Li WH., 2010. Inhibiting miRNA in Caenorhabditis elegans using a potent and selective antisense reagent. Silence 1: 9.